WTD STEERING COMMITTEE
Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC
Professor of Medicine
Hofstra Northwell School of Medicine
Professor, The Merinoff Center for Patient-Oriented Research
The Feinstein Institute for Medical Research
System Director – Anticoagulation and Clinical Thrombosis Services
Northwell Health System
New York, USA
Alex C. Spyropoulos, MD received his medical degree from the University of Pennsylvania School of Medicine in Philadelphia, PA, USA. He completed his internship and residency in internal medicine at the University of New Mexico Health Sciences Center in Albuquerque, NM. He is board certified in Internal Medicine.
Dr. Spyropoulos was founder and former Medical Director of the Clinical Thrombosis Center in Albuquerque, New Mexico. He is a Professor of Medicine at Hofstra, Northwell School of Medicine and System Director of Anticoagulation and Clinical Thrombosis Services for the multi hospital Northwell Health System in NY. He is also a Professor of the Merinoff Center for Patient-Oriented Research as part of the Feinstein Institute for Medical Research. He is co-chair of the Council on Leadership of Thrombosis at Northwell Health System. He is a Fellow of the American College of Physicians, American College of Chest Physicians, International Academy of Clinical and Applied Thrombosis/Haemostasis, and the Royal College of Physicians, Canada.
Dr. Spyropoulos has helped to develop protocols using Low Molecular Weight Heparin (LMWH) in outpatient-based treatment of venous thromboembolic disease, patient self-testing of warfarin, perioperative "bridging" for patients on chronic anticoagulation, medical inpatient thromboprophylaxis, protocols with regards to the use of anticoagulants for HIT, and clinical use of the direct oral anticoagulants, including their use in special patient populations and periprocedural situations. Dr. Spyropoulos is active in assessing outcome and pharmacoeconomic analyses of these protocols.
He has been involved as Principal Investigator, Scientific Committee member, Steering and Executive Committee member, or member of Data Safety Monitoring Board in multiple international, multicenter randomized trials in thrombosis and anticoagulant therapy, including the NHLBI-funded BRIDGE and Kids DOTT studies, the MARINER trial and the CIHR-funded PAUSE trial. He has been a panel member of multiple international antithrombotic guideline groups such as the ACCP 8th, 9th, and currently 10th edition. He is Section Editor for Thrombosis and Haemostasis, and is on the editorial staff for Thrombosis Research and Hospital Medicine. Dr. Spyropoulos has published over 160 research studies, articles, and editorials in peer-reviewed journals.